The rise of EIA/ELISA

Clinical Chemistry

Volumn 51, Issue 12, 2005, Pages 2226-

  Van Weemen, Bauke K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; HEPATITIS B SURFACE ANTIGEN;

AUTOMATION; CLINICAL CHEMISTRY; DIAGNOSTIC ACCURACY; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HORMONE DETERMINATION; LABORATORY TEST; LATEX AGGLUTINATION TEST; LICENSING; MEDICAL TECHNOLOGY; PREGNANCY TEST; REVIEW; VIRUS IDENTIFICATION;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTORY, 20TH CENTURY; HUMANS; PREGNANCY; PREGNANCY TESTS, IMMUNOLOGIC;

HEPATITIS B VIRUS;

EID: 28044465697     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.059626     Document Type: Review

References (4)

1. Lequin RM. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem 2005;51:2415-8.
2. Van Weemen BK, Schuurs AHWM. Immunoassay using antigen-enzyme conjugates. FEBS Lett 1971;15:232-6.
3. Schuurs AHWM, van Weemen BK, inventors. Method for the determination of antigens and antibodies. US Patent 3,654.090 (filed September 24, 1968; granted April 4, 1972).
4. Leuvering JH, Thai PJ, Van der Waart M, Schuurs AHWM. A sol particle agglutination assay for human chorionic gonadotrophin. J Immunol Methods 1981;45:183-94.